Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium

Annals of Pharmacotherapy

Volumn 46, Issue 12, 2012, Pages

  Mueller, Scott W ^a   Kiser, Tyree H ^a   Anderson, Tracey A ^b   Neumann, Robert T ^c,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO HOSPITAL   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Daptomycin; External ventricular drain; Intraventricular; Linezolid; Vancomycin resistant Enterococcus faecium; Ventriculitis

Indexed keywords

AMPICILLIN; CEFEPIME; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; GENTAMICIN; LINEZOLID; MYCOPHENOLIC ACID; PREDNISONE; STREPTOMYCIN; TERBINAFINE; VANCOMYCIN; VORICONAZOLE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APHASIA; ARTICLE; ATAXIA; BACTERIAL GROWTH; BRAIN BIOPSY; BRAIN VENTRICULITIS; CASE REPORT; CEREBROSPINAL FLUID CULTURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DRUG WITHDRAWAL; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EXTERNAL VENTRICULAR DRAIN ASSOCIATED VENTRICULITIS; FEVER; FUNGAL MENINGITIS; HEADACHE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; HYDROCEPHALUS; IMMUNOSUPPRESSIVE TREATMENT; INTRACRANIAL HYPERTENSION; LEUKOCYTE COUNT; MALE; MEDICAL HISTORY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; SCEDOSPORIUM APIOSPERMUM; TREATMENT DURATION; UNSTEADINESS; WEAKNESS;

ACETAMIDES; ADMINISTRATION, INTRAVENOUS; ANTI-BACTERIAL AGENTS; CEREBRAL VENTRICULITIS; DAPTOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRAINAGE; DRUG THERAPY, COMBINATION; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; MIDDLE AGED; OXAZOLIDINONES; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE;

EID: 84872231503     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R412     Document Type: Article

References (21)

1. Kim JH, Desai NS, Ricci J, et al. Factors contributing to ventriculostomy infection. World Neurosurg 2012;77:135-40.
2. Lyke KE, Obasanjo OO, Williams MA, O'Brien M, Chotani R, Perl TM. Ventriculitis complicating use of intraventricular catheters in adult neurosurgical patients. Clin Infect Dis 2001;33:2028-33.
3. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84.
4. Finberg RW, Moellering RC, Tally FP, et al. The importance of bactericidal drugs: future directions in infectious disease. Clin Infect Dis 2004;39: 1314-20.
5. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ES-KAPE! an update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:1-12.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S18. Wayne, PA: CLSI;2008.
7. Dandekar PK, Tessier PR, Williams P, Nightinggale CH, Nicolau DP. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model. J Antimicrob Chemother 2003;52:405-11.
8. Kullar R, Chin JN, Edwards DJ, Parker D, Coplin WM, Rybak MJ. Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections. Antimicrob Agents Chemother 2011;55:3505-9.
9. Le J, Bookstaver PB, Rudisill CN, et al. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother 2010;44:2001-6. doi: 10.1345/aph.1P333
10. Jaspan HB, Brothers AW, Campbell AJ, et al. Multidrug-resistant Enterococcus faecium meningitis in a toddler: characterization of the organism and successful treatment with intraventricular daptomycin and intravenous tigecycline. Pediatr Infect Dis J 2010;29:379-81.
11. Rybak MJ, Hershberger E, Moldovan T, Grucz RG. In vitro activities of daptomycin, vancomycin, linezolid, quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin-intermediate and resistant strains. Antimicrob Agents Chemother 2000;44:1062-6.
12. Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P. Daptomycin is more efficacious than vancomycin against methicillin-susceptible Staphylococcus aureus in experimental meningitis. J Antimicrob Chemother 2006;57:720-3.
13. Riser MS, Bland CM, Rudisill CN, Bookstaver PB. Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis. Ann Pharmacother 2010:44:1832-5. doi:10345/aph.1P307
14. Elvy J, Porter D, Brown E. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin. J Antimicrob Chemother 2008;61:461-2.
15. Kahler RC, Holloway K. Successful use of intrathecal daptomycin to treat meningitis due to vancomycin-resistant Enterococcus faecium. Infect Dis Clin Pract 2012;20:416-8. doi: 10.1097/IPC.0b013e3182506d8f
16. Erritouni M, Ktaich N, Rahal JJ, et al. Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis. Case Report Med 2012;2012:593-578. doi: 10.1155/2012/593578
17. Ziai WC, Lewin JJ. Improving the role of intraventricular antimicrobial agents in the management of meningitis. Curr Opin Neurol 2009;22:277-82. doi: 10.1097/WCO.0b013e32832c1396
18. Tängdén T, Enblad P, Ullberg M, Sjölin J. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011;52:1310-6. doi: 10.1093/cid/cir197
19. Pfausler B, Spiss H, Beer R, et al. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. J Neurosurg 2003;98:1040-4.
20. Product information. Cubicin (daptomycin). Lexington, MA: Cubist Pharmaceuticals, November 2010.
21. Blatter DD, Bigler ED, Gale SD, et al. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol 1995;16:241-51.